Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 배당금 정보
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.는 주당 0.109의 연간 배당금을 지급하며, 수익률은 0.00%입니다. 배당금은 연간에 지급되며, 마지막 배당금 지급일은 May 26, 2025였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
0.00%
$0.109
May 26, 2025
지급 빈도
지급 비율
연간
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
May 26, 2025
$0.2717
May 27, 2025
Jul 22, 2025
May 24, 2023
$0.1122
May 25, 2023
Aug 15, 2023
Jun 14, 2022
$0.0411
Jun 15, 2022
Aug 15, 2022
배당금 차트
SHEZF 배당금
SHEZF 배당금 성장률(년간 비교)
Follow-Up Questions
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.의 현재 배당금과 연간 배당금은 얼마인가요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.의 배당 성향은 얼마인가요?
SHEZF의 배당락일은 언제인가요?
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.은 얼마나 자주 배당금을 지급하나요?
주요 통계
이전 종가
$0.4696
시가
$0.7206
일일 범위
$0.4696 - $0.7206
52주 범위
$0.4696 - $0.7206
거래량
25
평균 거래량
0
EPS(TTM)
-0.02
배당수익률
--
시가총액
$103.3M
SHENZHEN HEPALINK PHARMACEUTICA란 무엇인가요?
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 1,926 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the heparin industry chain, contract development and manufacturing organization (CDMO) of biological macromolecules, and the investment, development, and commercialization of innovative drugs. The firm operates four segments. The Pharmaceutical Formulations segment manufactures and sells enoxaparin sodium injection and others. The Active Pharmaceutical Ingredients (APIs) segment manufactures and sells standard heparin APIs, enoxaparin APIs and others. The CDMO segment provides process development services for pharmaceutical intermediates and APIs, including process research, optimization, analytical testing, and formulation research. The Other segment engages in other product businesses, such as pancreatic enzymes and casings. The firm conducts its business in the domestic and overseas markets.